Riley Jeffrey Scott Insider Trades

Insider Trading History

Track insider trading activity for Riley Jeffrey Scott. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Gain Therapeutics
Gain Therapeutics GANX
Director
Holding Value $26.9k 15,000 shares
Last Trade
Jun 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$26.9k 15,000 shares
$1.79
$1.79
Gain Therapeutics
Gain Therapeutics GANX
Director
Holding Value $26.9k 15,000 shares
Last Trade
Jun 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.4k 15,000 shares
$1.29
$1.79
Gain Therapeutics
Gain Therapeutics GANX
Director
Holding Value $53.7k 30,000 shares
Last Trade
Mar 28, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$116k 30,000 shares
$3.86
$1.79
Gain Therapeutics
Gain Therapeutics GANX
Director
Holding Value $18.8k 10,500 shares
Last Trade
Jun 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.3k 10,500 shares
$4.50
$1.79
Gain Therapeutics
Gain Therapeutics GANX
Director
Holding Value $0 0 shares
Last Trade
Mar 17, 2021 Sale
No data
No data
$1.79
Theriva Biologics
Theriva Biologics SYN
Chief Executive Officer
Holding Value $1.15M 1,129,000 shares
Last Trade
Nov 30, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$315M 1,129,000 shares
$278.88
$1.02
Theriva Biologics
Theriva Biologics SYN
Chief Executive Officer
Holding Value $510k 500,000 shares
Last Trade
Dec 04, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$483M 500,000 shares
$966.00
$1.02
Theriva Biologics
Theriva Biologics SYN
CEO And President
Holding Value $357k 350,000 shares
Last Trade
Jan 08, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$189M 350,000 shares
$539.00
$1.02
Theriva Biologics
Theriva Biologics SYN
CEO And President
Holding Value $510k 500,000 shares
Last Trade
Apr 17, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$441M 500,000 shares
$882.00
$1.02
Theriva Biologics
Theriva Biologics SYN
CEO And President
Holding Value $10.6k 10,400 shares
Last Trade
Jan 07, 2013 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.77M 2,900 shares
$609.00
$1.02
Theriva Biologics
Theriva Biologics SYN
CEO And President
Holding Value $5.61k 5,500 shares
Last Trade
Jan 03, 2013 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.68M 2,800 shares
$598.50
$1.02
Theriva Biologics
Theriva Biologics SYN
CEO And President
Holding Value $7.65k 7,500 shares
Last Trade
Jan 03, 2013 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.2M 2,000 shares
$598.50
$1.02
Theriva Biologics
Theriva Biologics SYN
CEO And President
Holding Value $2.75k 2,700 shares
Last Trade
Jan 02, 2013 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.68M 2,700 shares
$623.00
$1.02
Theriva Biologics
Theriva Biologics SYN
CEO And President
Holding Value $926k 908,333 shares
Last Trade
Feb 03, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.73M 750,000 shares
$2.30
$1.02
Theriva Biologics
Theriva Biologics SYN
Director
Holding Value $161k 158,333 shares
Last Trade
Nov 17, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$49k 100,000 shares
$0.49
$1.02
Theriva Biologics
Theriva Biologics SYN
Director
Holding Value $59.5k 58,333 shares
Last Trade
Jan 05, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.5k 25,000 shares
$1.50
$1.02
Theriva Biologics
Theriva Biologics SYN
Director
Holding Value $34k 33,333 shares
Last Trade
Dec 02, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.17k 8,333 shares
$0.74
$1.02
Theriva Biologics
Theriva Biologics SYN
Director
Holding Value $0 0 shares
Last Trade
Mar 16, 2010 Sale
$27.8k 25,000 shares
$1.11
$1.02

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up